/ /

  • linkedin
  • Increase Font
  • Sharebar

    Alcaftadine superior in reducing itching from grass, tree pollens

     

    Minimal itching

    Alcaftadine was also superior in the category of subjects with minimal itching (less than 1 on a 4-point scale); in 95 grass-allergic subjects, 38 (79%) subjects who had received alcaftadine had a low score versus 25 (54%) of those who received olopatadine.

    Related: Getting to the root cause of ocular allergy

    In the study of tree-allergic subjects 24 hours after dosing (n=16), results 3 minutes post-CAC showed that the mean difference between alcaftadine (mean itching score of 0.50) and olopatadine (mean itching score of 1.38) was -0.88 (p=0.135).

    The change from baseline was -2.4 for alcaftadine versus -1.1 for olopatadine (p=0.048), which corresponded to a percentage change from baseline of -83.3% for alcaftadine versus -41.4% for olopatadine (p=0.045). Five patients treated with alcaftadine (83%) versus 2 (33%) who had received olopatadine reported minimal itching of less than 1 on the 0-4 itching scale (p=0.242).          

    More: Is it allergy or dry eye?

     

    Reference

    1Ono SJ, Lane K. Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis. Drug Design, Development and Therapy. 2011;5:77-84.

     

    Want More Cutting-Edge Advancements? Subscribe Here For Free eNewsletter

    More articles: 

    What clinicians should know about ocular allergies

    3 steps to improve ocular health of dry eye patients

    How new eye drop is stabilizing and relieving dry eye

    How to approach the management of seasonal allergies

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results